IRIS
CALZETTA, Luigino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.646
EU - Europa 2.148
AS - Asia 568
AF - Africa 25
SA - Sud America 8
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.401
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.631
IE - Irlanda 1.083
SE - Svezia 473
SG - Singapore 301
IT - Italia 206
CN - Cina 190
FI - Finlandia 107
DE - Germania 75
AT - Austria 65
EE - Estonia 38
IN - India 37
GB - Regno Unito 28
CI - Costa d'Avorio 21
BE - Belgio 19
CA - Canada 11
TR - Turchia 11
NL - Olanda 10
ID - Indonesia 9
RU - Federazione Russa 9
ES - Italia 6
IR - Iran 6
AR - Argentina 4
CH - Svizzera 4
FR - Francia 4
HR - Croazia 4
NZ - Nuova Zelanda 4
UA - Ucraina 4
HK - Hong Kong 3
HU - Ungheria 3
MX - Messico 3
TW - Taiwan 3
ZA - Sudafrica 3
BG - Bulgaria 2
BR - Brasile 2
JP - Giappone 2
PT - Portogallo 2
RO - Romania 2
VN - Vietnam 2
AL - Albania 1
AU - Australia 1
CL - Cile 1
CO - Colombia 1
EU - Europa 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MM - Myanmar 1
OM - Oman 1
PK - Pakistan 1
PR - Porto Rico 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 6.401
Salva come PNG Salva come JPEG
Città #
Chandler 1.266
Dublin 1.073
Ashburn 345
Princeton 256
Singapore 149
Des Moines 144
Helsinki 106
Wilmington 89
Beijing 70
Vienna 65
Ann Arbor 59
Shanghai 56
Tallinn 38
Rome 31
Chicago 29
Parma 27
Milan 26
Boardman 24
Abidjan 21
Bremen 19
Brussels 19
Fremont 19
Seattle 19
Redmond 18
New York 17
Los Angeles 15
Norwalk 15
Pune 15
Rockville 13
Bologna 12
Saint Louis 10
Nanchang 9
Naples 9
Borås 8
Edinburgh 8
Falls Church 8
Guangzhou 8
Houston 8
Kocaeli 8
Grafing 7
Kolkata 7
Yogyakarta 7
Phoenix 6
Trecasali 6
London 4
Solbiate Olona 4
Toronto 4
Vaddangi 4
Visakhapatnam 4
Zagreb 4
Barcelona 3
Budapest 3
Cape Town 3
Central 3
Izmir 3
Jinan 3
Miami 3
Montechiarugolo 3
Nocera Inferiore 3
Pozzuoli 3
Quartu Sant'Elena 3
Radeberg 3
St Petersburg 3
Taipei 3
Turin 3
Washington 3
Zurich 3
Andover 2
Belsize Park 2
Bengaluru 2
Boston 2
Cassino 2
Chekhov 2
Chesham 2
Chiesina Uzzanese 2
Cipolletti 2
Columbus 2
Correggio 2
Council Bluffs 2
Cremona 2
Cumignano sul Naviglio 2
Forest City 2
Huizen 2
Lecce 2
Macerata 2
Macerata Campania 2
Maryville 2
Modena 2
Montichiari 2
Monza 2
Moscow 2
Nanjing 2
New Orleans 2
Padova 2
Plymouth Meeting 2
Redwood City 2
Reggio Calabria 2
Richmond Hill 2
Salerno 2
San Mateo 2
Totale 4.305
Salva come PNG Salva come JPEG
Nome #
Distribution of the Clinical Manifestations of Alpha 1 Antitrypsin Deficiency in Respiratory Outpatients from an Area of Northern Italy 96
The COPD assessment test and the modified Medical Research Council scale are not equivalent when related to the maximal exercise capacity in COPD patients 87
Small airways in asthma: from bench-to-bedside 84
Advances in understanding of mechanisms related to increased cardiovascular risk in COPD 82
Coronavirus Disease 2019: COSeSco - A Risk Assessment Score to Predict the Risk of Pulmonary Sequelae in COVID-19 Patients 68
Dexamethasone in patients hospitalized with COVID-19: Whether, when and to whom 62
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: An Italian Multicenter Study 57
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian Multicenter Study 54
Clinical manifestations of a new alpha-1 antitrypsin genetic variant: Q0parma 54
The impact of monoclonal antibodies on airway smooth muscle contractility in asthma: A systematic review 53
A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD 50
Detection of Small Airway Dysfunction in Asthmatic Patients by Spirometry and Impulse Oscillometry System 48
Detection of small airway dysfunction in asymptomatic smokers with preserved spirometry: The value of the impulse oscillometry system 48
Targeting IL-5 pathway against airway hyperresponsiveness: A comparison between benralizumab and mepolizumab 48
The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma 46
The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review 46
Analysis of exhaled breath fingerprints and volatile organic compounds in COPD 46
Multi-walled carbon nanotubes induce airway hyperresponsiveness in human bronchi by stimulating sensory C-fibers and increasing the release of neuronal acetylcholine 44
Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis 44
A 6MWT index to predict O-2 flow correcting exercise induced SpO(2) desaturation in ILD 43
Sars-cov-2 neutralizing antibodies: A network meta-analysis across vaccines 43
An Impairment in Resting and Exertional Breathing Pattern May Occur in Long-Covid Patients with Normal Spirometry and Unexplained Dyspnoea 42
The 5T approach in asthma: Triple Therapy Targeting Treatable Traits 42
Ventilation Heterogeneity in Asthma and COPD: The Value of the Poorly Communicating Fraction as the Ratio of Total Lung Capacity to Alveolar Volume 42
Can placebo challenge test (Inducing a “nocebo effect”) be a suitable model to assess stress-induced bronchial obstruction? suggestions from the multidisciplinary working groups “stress-asthma” and “AAIITO regione campania” 42
Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics 42
Assessment of pet exposure by questionnaires in epidemiological studies (but also in clinical practice!): Why the questions should be simplified? 41
Oral corticosteroids dependence and biologic drugs in severe asthma: Myths or facts? a systematic review of real‐world evidence 41
SMART for the treatment of asthma: A network meta-analysis of real-world evidence 41
Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review 41
Face masks during COVID-19 pandemic lockdown and self-reported seasonal allergic rhinitis symptoms 41
Cardiovascular disease in copd 41
Medium-dose ICS-containing FDCs reduce all-cause mortality in COPD patients: an in-depth analysis of dual and triple therapies 40
ANTI-INFLAMMATORY PROFILE OF N-ACETYLCYSTEINE IN HUMAN BRONCHI STIMULATED WITH LIPOPOLYSACCHARIDE 38
Dog allergy: can a prevalent or exclusive sensitization to Can f 5 be considered a lucky or negative event in real life? 38
Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis 38
Advances with glucocorticoids in the treatment of asthma: state of the art 38
Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs 37
The impact of comorbidities on severe asthma 37
Dysfunction of small airways and prevalence, airway responsiveness and inflammation in asthma: much more than small particle size of pet animal allergens 36
Preclinical Evaluation of an Inhibitor of Cytosolic Phospholipase A(2)alpha for the Treatment of Asthma 36
A safety comparison of LABA plus LAMA vs LABA plus ICS combination therapy for COPD 36
Onset of action of budesonide/formoterol Spiromax (R) compared with budesonide/formoterol Turbuhaler (R) in patients with COPD 36
Allergy in adolescent population (14-18 years) living in Campania region (southern Italy). A multicenter study 36
Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: A translational bench-to-bedside study 36
Clinical efficacy of bronchodilators in equine asthma: Looking for minimal important difference 36
Long-acting bronchodilators and synergistic interaction: a challenge across the currently available LABA/LAMA combinations 35
Synergistic interaction between beclomethasone diproprionate and formoterol fumarate in an ex vivo model of bronchial asthma 35
Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate plus vilanterol for the treatment of asthma 35
Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination 35
Reduced risk of COVID-19 hospitalization in asthmatic and COPD patients: a benefit of inhaled corticosteroids? 34
Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients 34
The possible concomitant use of aeroallergen and food panels for skin prick testing might enhance the risk of generalized allergic reactions in children 34
Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to Patients 34
Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed 33
Reply to Han et al.: impact on mortality of triple ICS/LABA/LAMA therapy in a population of COPD patients including also subjects with asthma-like profile 33
Response to letter to the editor. Again on IMPACT: exacerbation after abrupt discontinuation of ICS and pneumonia in fluticasone furoate-containing FDCs 33
Immunoprophylaxis pharmacotherapy against canine leishmaniosis: A systematic review and meta-analysis on the efficacy of vaccines approved in European Union 33
ACLIDINIUM/FORMOTEROL FIXED-DOSE COMBINATION FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 32
Adding a LAMA to ICS/LABA Therapy A Meta-analysis of Triple Combination Therapy in COPD 32
Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond 32
The influence of propofol, remifentanil and lidocaine on the tone of human bronchial smooth muscle 32
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 32
Optimizing drug delivery in COPD: The role of inhaler devices 32
Effect of lipopolysaccharide on the responsiveness of equine bronchial tissue 32
Anthelminthic medicinal plants in veterinary ethnopharmacology: A network meta-analysis following the PRISMA-P and PROSPERO recommendations 32
Can an increased cholinergic tone constitute a predictor of positive response to tiotropium in patients with moderate asthma? 31
Epithelial-smooth muscle cooperation is needed for brain natriuretic peptide-dependent bronchorelaxant activity 31
The discovery of roflumilast for the treatment of chronic obstructive pulmonary disease 31
Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus 31
Indacaterol, glycopyrronium, and mometasone: Pharmacological interaction and anti-inflammatory profile in hyperresponsive airways 31
A pilot survey on the quality of life in respiratory rehabilitation carried out in COPD patients with severe respiratory failure: preliminary data of a novel Inpatient Respiratory Rehabilitation Questionnaire (IRRQ) 30
LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment 30
LAMA/LABA Fixed Combinations for COPD Management: A Systematic Comparative Review 30
Emerging drugs for chronic obstructive pulmonary disease 30
Factors influencing the efficacy of COVID-19 vaccines: A quantitative synthesis of phase III trials 30
Unmet needs and relationship between general practitioners (GPS) and allergists living in Campania region (Southern Italy) 30
Pharmacology and Therapeutics of Bronchodilators 29
Ensifentrine (RPL554): an inhaled "bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary disease 29
Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses 29
Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review 29
Long-acting muscarinic antagonists under investigational to treat chronic obstructive pulmonary disease 29
Brain natriuretic peptide modulates calcium homeostasis and epidermal growth factor receptor gene signalling in asthmatic airways smooth muscle cells 28
Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens 28
Chronic cat allergen exposure and low sensitization: Possible limitations in patient selection? 28
Brensocatib: Dipeptidyl peptidase 1 (DPP1) inhibitor Treatment of non-cystic fibrosis bronchiectasis 28
Pharmacogenetic and pharmacogenomic considerations of asthma treatment 27
Diabetes mellitus among outpatients with COPD attending a university hospital 27
Step-up and step-down approaches in the treatment of asthma 27
Anxiety and depression in adolescents with asthma and in their parents. Is an increased basal cholinergic tone a possible further reason to explain the negative impact on asthma control? 27
Anxiety/depression and impaired asthma control in adolescents. Is an increased basal cholinergic tone a possible link? 27
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS Score 26
Use of indacaterol for the treatment of COPD: a pharmacokinetic evaluation 26
Is ICS-LAMA an alternative option to treat patients with COPD? 26
Partial nephrectomy using radiofrequency incremental bipolar generator with multi electrode probe: experimental study in bench pig kidneys 26
Asthma and COPD in an Italian adult population: Role of BMI considering the smoking habit 26
Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma 26
Oxidation pathway and exacerbations in COPD: the role of NAC 26
The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis (vol 12, pg 3469, 2017) 26
Sex differences in COPD management 26
Totale 3.802
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.563
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020200 2 0 0 0 0 0 0 0 1 7 1 189
2020/202194 0 0 0 7 3 3 0 19 32 20 5 5
2021/20221.118 1 10 2 20 76 39 257 75 46 3 37 552
2022/20233.942 509 313 229 258 277 455 49 276 1.378 28 134 36
2023/20241.415 100 161 56 65 141 259 103 82 63 99 102 184
2024/202543 43 0 0 0 0 0 0 0 0 0 0 0
Totale 6.817